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Summary 
Congenital insensitivity to pain with anhidrosis (CIPA) or hereditary sensory and 
autonomic neuropathy type IV (HSAN-IV) is an autosomal recessive disorder 
characterized by recurrent episodic fevers, anhidrosis (inability to sweat), absence of 
reaction to noxious (or painful) stimuli, self-mutilating behavior and mental 
retardation. The anomalous pain and temperature sensation and anhidrosis in CIPA are 
due to the absence of afferent neurons activated by tissue-damaging stimuli and a loss of 
innervation of eccrine sweat glands, respectively. Nerve growth factor (NGF) supports 
the survival of nociceptive sensory and autonomic sympathetic neurons as well as 
cholinergic neurons of the basal forebrain. The human TRKA(NTRK1) gene located on 
chromosome 1 (1q21-q22) encodes a receptor tyrosine kinase (RTK) which is 
autophosphorylated in response to NGF, thus, activating various pathways of 
intracellular signal transduction. We earlier identified the genetic basis of CIPA by 
detecting mutations in TRKA gene of patients. Defects in NGF signal transduction at its 
receptor lead to failure to survive as various NGF dependent neurons are not 
maintained, most probably due to apoptosis during development. TRKA mutations are 
distributed in an extracellular domain involved in NGF binding, as well as in the 
intracellular signal-transduction domain. Missense mutations with loss of function 
provide considerable insight into the structure-function relationship in the RTK family. 
In view of the fact that defects in TRKA cause CIPA, the molecular pathology of CIPA 
provides unique opportunities to explore critical roles of the NGF-TRKA receptor 
system. Thus, CIPA can serve as a useful model to determine mechanisms of 
development and maintenance of NGF-dependent neurons in autonomic, sensory and 
central nervous systems, as well as the physiology of these neurons in humans.  
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Introduction 
 
Congenital insensitivity to pain with anhidrosis (CIPA: MIM 256800) or hereditary sensory 
and autonomic neuropathy type IV (HSAN-IV) is an autosomal recessive disorder 
characterized by recurrent episodic fever, anhidrosis (inability to sweat), absence of reaction 
to noxious (or painful) stimuli, self-mutilating behavior and mental retardation [1,2]. The 
anomalous pain and temperature sensation and anhidrosis in CIPA are due to the absence of 
afferent neurons activated by tissue-damaging stimuli and a loss of sympathetic innervation 
of eccrine sweat glands, respectively [3-5]. Diminished pain perception results in decreased 
ability to protect oneself from external or self-inflicted-damage. Therefore children with 
CIPA can sustain severe and unrecognized injury. Loss of sympathetic innervation of eccrine 
sweat gland explains the phenomenon of anhidrosis [3, 5]. Because sweating plays an 
important role in maintaining normothermia under hot environmental conditions, anhidrosis 
disturbs homeostasis and increases susceptibility to recurrent febrile episodes.      
During the past decade there have been major advances in understanding factors related 
to survival as well as the death of neuronal cells. Although mature neurons are among the 
most long-lived cell types in mammals, immature neurons die in large numbers during 
development [6]. Neuronal survival requires trophic support. Nerve growth factor (NGF), a 
neurotrophic factor, induces neurite outgrowth and promotes survival of embryonic sensory 
and sympathetic neurons derived from the neural crest and ascending cholinergic neurons of 
the basal forebrain [7]. Nociceptive sensory neurons that respond to tissue damage are 
NGF-dependent for development, survival and maintenance.  
The TRKA(NTRK1) gene located on chromosome 1 (1q21-q22) encodes a receptor 
tyrosine kinase (RTK) which is autophosphorylated in response to NGF, thus, activating 
various pathways of intracellular signal transduction [8, 9]. Mice lacking the gene for NGF or 
TRKA (trkA) share phenotypic features with individuals affected with CIPA [10], including 
loss of responses to painful stimuli, although anhidrosis is not apparent in these animals. 
Using a candidate gene strategy, the genetic basis of CIPA was identified when 
loss-of-function mutations in TRKA (NTRK1) were noted in patients [11]. 
CIPA is the first human genetic disorder implicated in the signal transduction system of 
neurotrophic factors. Defects in NGF signal transduction at its receptor lead to failure to 
survive as various NGF dependent neurons are not maintained, most probably due to 
apoptosis during development. CIPA can serve as a useful model to determine mechanisms of 
development and maintenance of NGF-dependent neurons in autonomic, sensory and central 
 3
 
 
  
nervous system. In view of the fact that defects in TRKA cause CIPA, study of the 
pathophysiology of CIPA can provide unique opportunities to explore critical roles for the 
NGF-TRKA receptor system in humans, in particular the role of the NGF-TRKA systems in 
the development and function of nociceptive reception as well as thermoregulation via 
sweating. 
 
 
Clinical aspects of CIPA 
 
Swanson was the first to describe two male siblings with congenital insensitivity to pain and 
anhidrosis and noted that temperature sensation was also defective [1]. Pinsky and DiGeorge  
described the same disorder in three mentally retarded children, including two siblings [12]. 
All five patients manifested recurrent febrile episodes, repeated traumatic and thermal 
injuries, self-mutilating behavior and mental retardation. Sweating could not be elicited by 
thermal, painful, emotional, or chemical stimuli. In 1951, a case of “generalized anhidrosis” 
was reported in Japan that had many features similar to CIPA [13]. Rosenberg compiled a 
large review of 32 cases in 1994 [14]. 
 
Clinical features 
 
Recurrent episodic fevers are usually the first clinical sign and can begin in infancy or early 
childhood depending on environmental temperature. Because the children do not sweat, they 
develop hyperthermia when they are in a hot environment. They can also develop 
hypothermia when exposed to extreme cold [1]. 
Initially impaired pain perception may not be apparent but parents may recall that their 
children did not cry during blood sampling. Biting of tongue or lip starts after the first teeth 
erupt and can result in a bifid or absent tongue. Biting of the fingers and ulcerated fingertips 
are common. Bruises, cuts, and burns do not elicit normal reactions and are often 
unrecognized. Accidental injuries such as falls or burns lead to multiple scars, and bone or 
joint fractures can be complicated by deep infections such as osteomyelitis. Amputations of 
fingers or limbs are common as a result of these complications. Abnormal deformity of the 
joints (neurogenic arthropathy) is often present and need surgical procedures. Life span is 
variable. Twenty percent of affected children succumbed to hyperpyrexia within the first 3 
years of life [14]. Generally, toilet training is delayed and some CIPA children remain 
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incontinent of urine and feces [12,15]. 
 
Physical examination 
 
The skin is warm and dry with thickening of the soles and the palms, and often there are scars 
and abrasions [15]. Distribution of hair on the scalp and body is normal. Palmoplantar 
hyperkeratosis with significant fissuring of the plantar skin is common. Some CIPA children 
develop painless deep heel ulcers that are slow to heal [16]. The tip of the tongue, lip edges, 
and the distal ends of fingers are often missing. Fungiform papillae are invariably observed 
on the tongue. Orthopedic deformities may be noted, especially at the elbow, knee, and ankle 
joints [3]. Microcephaly is reported occasionally [14]. 
 
Neurological examination 
 
Insensitivity to superficial and deep painful stimuli is confirmed when painful stimuli fail to 
evoke either withdrawal or emotional change [1]. No tenderness or pain sensation is elicited 
even when apparently injured or broken joints are moved passively or actively. Temperature 
perception is impaired. Consistent errors are made in distinguishing between hot and cold 
moist substances. Extreme cold or heat fails to elicit the usual withdrawal response. Visceral 
pain perception is also impaired. Touch, vibration and position senses are normal, but ability 
to discriminate between sharp and dull stimuli may be disturbed. 
Most children with CIPA are mentally retarded, but test results can be variable [14].  
Children demonstrate defects in conceptual thinking, abstract reasoning, and social behavior 
and manifest symptoms of moderate to severe emotional disturbance [1, 12]. Behavior is 
characterized as labile, hyperactive, and erratic. They have a low frustration tolerance, resort 
to tantrums in an effort to gratify impulsive wishes, and avoid attempts to establish 
interpersonal relationships. Recurrent febrile convulsions are also observed and can be 
induced by high environmental temperature [17].  
Peripheral motor and cranial nerve function are normal. Deep tendon reflexes are 
normal, as well as superficial abdominal and cremasteric reflexes; there are no pathological 
reflexes [12]. Sense of smell is assumed to be normal. Corneal reflexes are inconsistently 
present. Blinking and lacrimation are normal [14]. Although chronic conjunctivitis and 
corneal ulcerations are uncommon, they may occur as a result of some corneal hypoesthesia 
and develop into corneal opacities or active corneal ulcers [18]. These corneal ulcers are 
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characterized by very poor healing, and sometimes require surgical interventions.  
 
Laboratory examination 
 
Routine examinations of blood, urine, and cerebrospinal fluid are normal. Chromosome 
analysis in the majority of the patients is normal. Radiographic studies may show numerous 
fractures of the lower extremity long bones [3, 14 ]. The knees and ankles often show 
neurogenic arthropathy (Charcot joint). Bone fractures are slow healing, and may develop 
chronic inflammation resulting in systemic amyloidosis [19]. Some patients may show a 
multisystem involvement extending beyond the nervous system, suggesting immunological 
abnormalities.  
Neurological laboratory studies such as EEG and CT scan are normal in the majority of 
the patients, but nonspecific dilatation of the third or the lateral cerebral ventricle has been 
observed in some patients [1, 20]. Electrophysiological studies reveal interesting findings. 
Conventional motor and orthodromic sensory conduction velocities by electrical and 
mechanical stimuli are usually normal. Similarly, somatosensory, visual and brainstem 
evoked potentials are normal. However, repeated trauma with severe neurogenic arthropathy 
can cause abnormalities of evoked sensory potential in the lower extremities [3]. 
Microneurography shows neural activity from A-beta sensory fibers connected to 
low-threshold mechanoreceptors, while nociceptive and skin sympathetic C fiber nerve 
activity is absent [21]. Moreover, intraneural electrical stimulation that produces unbearable 
pain in normal controls does not evoke any painful sensation. In a pure motor bundle, 
stretching of the muscle evokes intraneural activity from mechanoreceptor units. The 
sympathetic skin response is absent. 
 
Special studies 
 
Pharmacological tests and evaluation of the autonomic function are useful for clinical 
diagnosis as well as for elucidation of pathophysiology.  
 
Pain tests 
Painful stimuli that fail to evoke either withdrawal or emotional change include pin prick; 
vigorous pressure on the Achilles tendons, the testes, the stylomastoid processes, and the 
superior orbital rim; burning heat; immersion of the limbs in ice water; galvanic electrical 
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stimulation of skin; and prolonged ischemia of the limbs [1]. Visceral pain perception is 
impaired since no discomfort is elicited when a balloon is inflated in the lower esophagus. 
There is no discomfort during or after pneumoencephalograms, which often induce 
headaches. Strong electrical shocks, intramuscular injection of potassium chloride, and 
urinary catheterization fail to produce painful responses [15]. Stimulation of the tooth pulp 
did not produce evoked cortical sensory potentials in Swanson’s surviving patient [22].  
Interestingly, ultra-violet light does not produce erythema or tanning after prolonged 
exposure [15]. 
 
Histamine test
The axon reflex results from a stimulus applied to one branch of a nerve that induces an 
impulse that moves centrally to the point of division of the nerve (Fig. 1). The impulse is 
reflected down the other branch to the effector organ. Cutaneous pain fibers have branches 
reaching the arterioles and afferent (orthodromic) pain impulses pass antidromatically to the 
arterioles causing reflex vasodilation. The axon reflex is studied with an intradermal injection 
of histamine [1], which produces a wheal but no diffuse area of erythema that would 
correspond to a flare response. In individuals with CIPA and other HSANs, the injection and 
the post-injection period is not perceived as painful in contrast to control subjects who 
complain of burning pain or pruritis in the axon flare area.   
 
Sweating tests 
Sweat glands can be directly stimulated by intradermal injection of a cholinergic reagent and 
the sweat secretion visualized by the iodine-starch method [23]. In individuals with CIPA, 
neither pilocarpine nor methacholine (mecholyl) stimulate local sweating [12]. With 
warming, slight moisture of the intertriginous areas of the skin of the neck, axillae, and groin 
can occur, but no definite sweating is noted. The intertriginous moisture is probably caused 
by delayed evaporation of insensible water [1]. Emotional sweating responses are not 
observed by studying the electrical resistance of the palmar surfaces. Pinprick, deep pain, and 
startling sound fail to produce a change in skin resistance. Electrical stimulation and 
intradermal injection of norepinephrine also fail to evoke local sweating [1]. 
 
Autonomic nervous system 
Studies of sympathetic vasomotor control are intriguing [1]. Valsalva maneuver produces a 
drop in blood pressure followed by a normal overshoot. There is no postural hypotension, as 
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tilting does not cause a blood pressure decrease. However, infusion of norepinephrine 
produces a rise in systolic pressure with erythematous blotching of the face and forehead, 
suggesting supersensitivity to exogenous vasopressor substance [12]. The cold pressor test, 
submersion of the forearm in ice-cold water, causes no increase in blood pressure. In fact, a 
slight fall in blood pressure during a cold-pressor test has been reported, suggesting a 
paradoxical response [1]. Carotid sinus massage, ocular pressure, and external auditory 
meatus mechanical stimulation do not alter heart rate [15]. 
Ophthalmologic examination often reveals mild bilateral ptosis [15]. The pupils are 
mildly miotic and equal. Ciliospinal (skin-pupillary) reflex is absent. A diagnosis of 
“congenital bilateral Horner’s syndrome” was made in one patient, because of the 
combination of bilateral mild ptosis, bilateral anhidrosis, midposition pupils which failed to 
dilate in darkness but were briskly reactive to light, convergence and accommodation [15].   
The same authors described pharmacological studies on the ocular autonomic nervous 
system. Epinephrine instilled into the conjunctival sac produced dilatation. Cocaine produced 
no response. Methacholine (Mecholyl) produced a miosis within one half hour in a dark 
room, but this response could not be seen in a lighted room. The pupillary response to 
adrenaline and cocaine is consistent with sympathetic denervation and, possibly, some degree 
of secondary end-organ hyposensitivity [15]. Subcutaneous administration of methacholine 
or neostigmine, in a dose capable of producing lacrimation in normal children, fails to do so 
in the CIPA children, despite their ability to lacrimate spontaneously [12]. 
 
Histopathological studies 
 
Nerve biopsies 
Electron microscopy studies of the cutaneous branch of the radial nerve reveal complete 
absence of small myelinated and unmyelinated fibers without degenerative or regenerative 
changes [3]. Reduction in the number of unmyelinated and small myelinated fibers of the 
sural nerve was found in most of the specimens from this disorder studied by electron 
microscopy and these results were confirmed by morphometric analysis [24-26]. The 
histogram of the control nerve is typically bimodal; the histogram of the CIPA individual’s 
nerve is unimodal. Very few Schwann cells, apparently related to unmyelinated axons, are 
seen [3].  
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Skin biopsy 
The pathology of the skin is normal in most cases of CIPA. Nonspecific changes are 
occasionally in the epidermis that are considered secondary to repeated trauma [3]. Dermal 
nerves are normal in number and in appearance by silver stain light microscopy. Sweat glands 
on skin biopsy appear normal [1, 12] and histologic studies also demonstrate normal sweat 
and sebaceous glands and normal hair follicles [15] as well as normal nerve receptors such as 
Pacinian and Meissner’s corpuscles [20].  
Electron microscopic examination, however, reveals lack of innervation of the eccrine 
sweat glands with loss of unmyelinated sudomotor fibers, which could explain the anhidrosis 
[3, 5]. Sweat glands are not atrophic but intensively PAS-positive, in contrast to controls 
where most glands are PAS-negative or weakly positive [25]. The lumens of sweat glands 
appear smaller than in controls. Nerve bundles in the dermis seem to be slightly reduced in 
number and size, compared with those of controls. Normal myelinated nerve fibers are 
present in the subcutaneous tissue and similar but smaller nerve fibers are seen in the dermis, 
but no nerve endings are demonstrated in the epidermis [17]. Furthermore, no cell processes 
or unmyelinated axons are seen near or around the sweat glands; eccrine sweat glands are 
surrounded by loose collagen fibers and granular material outside the basal lamina of 
epithelial and myoepithelial cells.  
Recently, immunohistochemistry has demonstrated absent innervation of skin as well as 
of sweat glands. The lack of C and A-delta fibers in the skin is consistent with the loss of 
unmyelinated and small myelinated fibers in the sural nerve biopsy [21] and provides a 
morphological basis for insensitivity to pain and anhidrosis. The same study reports an 
almost complete absence of dermal fibers to blood vessels and erector pilomotor muscles 
[21]. 
 
Autopsy 
Autopsy was performed in only one case [4]. The younger of two boys that Swanson had 
reported died suddenly at the age of 12 years after a 24-hr febrile illness during which his 
body temperature exceeded 43° C. Hemorrhages were noted in many tissues and attributed to 
the high fever. Normal autonomic ganglion cells were found in the intestinal tract and the 
skin had abundant sweat glands.  
No obvious gross abnormalities were recognized in the brain or brainstem. In spite of the 
mild dilatation of the lateral ventricles previously demonstrated by pneumoencephalography 
[1], the ventricular system was normal post-mortem. On microscopic examination of the 
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brainstem, the spinal tract of the trigeminal nerve was about one third of normal. The 
majority of fibers in this tract were of large diameter, and there was a marked decrease in 
number of fine, lightly myelinated axons. Sections of the posterior ventral lateral nucleus of 
the thalamus and the somatosensory cortex were normal. No abnormalities were identified in 
the sympathetic ganglia or in the intermediolateral cell column of the spinal cord. The 
autonomic ganglia also appeared normal, but quantitative counts were not performed [1]. 
The spinal dura mater was thickened with a unique and unexplained abnormality 
consisting of two slit-like cavities, one dorsal and one ventral. Lissauer’s tract (dorsolateral 
fasciculus) could not be identified in myelin or axon-stained sections at any level of the 
spinal cord. Cross sections of dorsal roots demonstrated a nearly uniform large fiber 
population with only a few scattered small fibers, in contrast to the normal picture of 
intermingled large and small myelinated fibers. In dorsal ganglia, an almost uniform 
population of large neurons replaced the normal pattern of large and small ganglion cells. The 
cells of the substantia gelatinosa and the anterior and posterior commissures were normal in 
number and morphology. The spinothalamic tracts could not be specifically identified, but the 
lateral and ventral columns of the spinal cord appeared normal. 
In summary, the abnormalities were absence of small neurons in the dorsal ganglia, lack 
of small fibers in the dorsal roots, absence of Lissauer’s tract, and reduction in size of the 
spinal tract of the trigeminal nerve with paucity of small fibers. These findings represent 
almost complete absence of the first order afferent system generally considered responsible 
for pain and temperature sensation [1]. 
 
Diagnosis 
 
The diagnosis of CIPA is initially based upon clinical features of impaired senses of pain and 
temperature, the absence of sweating, the presence of disseminated bruises and scars, bone 
fractures and joint deformities which may lead to amputation, and mental retardation [14].   
Supporting the diagnosis is the frequent history of bouts of fever in early life. Skin tests 
demonstrating abnormalities in sweating and the lack of the axon reflex provide further 
evidence for diagnosis. Until recently, skin and nerve biopsies were used to confirm 
diagnosis, but now molecular DNA diagnosis using peripheral blood samples is possible. 
If a TRKA mutation responsible for CIPA is identified in a family, it is now technically 
possible to do prenatal genetic testing. Genetic counseling should be provided and 
consideration given to ethical issues when performing the procedure.  
 10
 
 
  
 
Treatment 
 
No specific therapy is available at present but supportive therapy is important. Clinically, 
CIPA is a serious illness that may be fatal in the first few years of life, if hyperpyrexia is not 
properly corrected. In older children, osteomyelitis and bone and/or joint deformities demand 
surgical procedures and may even require amputations. Special training programs to prevent 
self-mutilation and accidental injuries are necessary but may be hampered by the low level of 
intelligence of these patients [14]. 
 
 
Nerve growth factor and receptor tyrosine kinase, TRKA 
 
Neurotrophins and neurotrophic theory 
 
The development and maintenance of cellular communication networks within the central 
and peripheral nervous system are regulated by neurotrophic factors, referred to as 
neurotrophins. Neurotrophins bind and activate specific cell surface receptors, generating 
differentiation and survival signals in various neurons. Each of the neurotrophins described to 
date - nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 
(NT-3) and neurotrophin-4 (NT-4) - exerts similar functional effects, but on different neuronal 
populations [27, 28].  
The neurotrophic hypothesis proposes that immature neurons compete for target-derived 
trophic factors that are of limited supply; only those neurons that are successful in 
establishing correct synaptic connections would obtain trophic factor support to allow for 
survival. Neurotrophic factors function as survival signals and suppress a cellular suicide 
program (apoptosis); deprivation of those factors activates cell death [6].  
NGF was the first growth factor to be identified and characterized [7] and it is the 
prototypic neurotrophin. NGF supports the survival of sympathetic ganglion neurons and 
nociceptive sensory neurons in dorsal root ganglia, derived from the neural crest, and 
ascending cholinergic neurons of the basal forebrain [7]. For over 50 years since its initial 
discovery, NGF has occupied a central position in developmental neurobiology [29-31]. 
There are two unique features of NGF’s action on neurons as opposed to those of growth 
factors on other cell types [29, 32]. First, NGF regulates functions of differentiated neurons, 
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i.e., growth as opposed to proliferation. Second, NGF is synthesized at a considerable 
distance from the cell body by peripheral tissues or other neurons (referred to as targets) that 
are contacted by axons of the NGF-sensitive neurons. The secreted NGF is thought to have 
local effects on axons of innervating neurons as well as more general influences on gene 
expression after it reaches the cell body via the process of retrograde transport. Most 
investigators have favored the view that target-derived NGF matches the number and 
properties of innervating neurons to the needs of the target tissue [30-32].   
 
Structure and biochemistry of NGF 
 
All neurotrophins have similar biochemical characteristics. They are secretary proteins that 
are synthesized as precursor proteins. The mature (or processed) part of all neurotrophins 
show a high degree of sequence homology, and approximately 50% of the amino acids are 
common to all neurotrophins, although the precursor sequences diverge significantly. 
The mature active form of NGF in the mouse submandibular gland, the source for most 
studies, consists of a tightly associated dimer of two identical 118-amino acid polypeptide 
chains [33, 34]. Human mature NGF consists of 120–amino acids [35]; it contains two more 
residues than the mouse protein because the carboxy-terminal dipeptide is not excised [33].   
 
Discovery of receptors for NGF 
 
Early studies revealed that NGF receptors on various neuronal populations and on tumor cell 
lines were heterogeneous with regard to binding affinity and binding kinetics; the distinct 
receptor populations were referred as low and high affinity or as kinetically fast and slow 
[28]  
 
p75 neurotrophin receptor 
The first receptor to be cloned was the low-affinity receptor, p75 neurotrophin receptor 
[36-38]. This receptor binds all neurotrophins with similar affinity but its functional role and 
signaling capacity has remained elusive. The p75 neurotrophin receptor is the founding 
member of the TNF receptor superfamily [39]. NGF binding to p75 neurotrophin receptor 
results in the hydrolysis of sphingomyelin to ceramide [40]. The similarity in the intracellular 
domain of the p75 neurotrophin receptor with other members, such as the Fas antigen and the 
p55 TNF receptor, suggests that the p75 neurotrophin receptor might also function as a cell 
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death molecule. 
 
TRKA , receptor tyrosine kinase for NGF 
The TRK family of receptor tyrosine kinases was first identified in 1986 when the trk gene 
(TRKA ) was found to be part of an oncogene isolated from a human colon carcinoma [41, 
42]. The physiological role of TRKA protein was unveiled when it was shown to be the 
signaling receptor for NGF [8,9]. Other members of the TRK family include TRKB, the 
signaling receptor for BDNF and NT-4; and TRKC, the primary receptor for NT-3 [27]. NT-3 
also binds to TRKA and TRKB, but with significantly lower affinity. 
TRKA is phosphorylated in response to NGF and is essential for intracellular signal 
transduction [43]. The binding of NGF to TRKA stimulates homodimer formation and 
activation of tyrosine kinase activity (Fig. 2). A single transmembrane domain divides the 
TRKA protein into extracellular and intracellular domains [27, 44]. The extracellular domain 
is important for specific NGF binding and includes a signal peptide, three tandem 
leucine-rich motifs flanked by two cysteine clusters, and two immunoglobulin-like domains 
(or motifs). The intracellular domain, including a juxtamembrane region, a tyrosine kinase 
domain, and a very short carboxy-terminal tail, is phosphorylated in response to NGF and is 
critical for intracellular signaling. Phosphorylated tyrosine residues in the TRKA cytoplasmic 
domain serve as anchors for binding downstream signaling molecules [27, 28]. In vitro 
assessment has identified TRKA tyrosine residues - 490, 670, 674, 675 and 785 as 
autophosphorylation sites [45]. 
 
Gene Knockout Mice of NGF, p75 Neurotrophin Receptor and TRKA 
 
Mice lacking NGF or its receptors have remarkable neurological deficits. 
 
NGF knockout mice 
To study the effects of NGF depletion on both central and peripheral neurons, the NGF gene 
was disrupted, using homozygous recombination in embryonic stem cells [46]. Mice 
heterozygous for NGF gene disruption grow and breed normally. Mice that are homozygous 
for the disrupted allele display severe perinatal cell loss in the dorsal root and sympathetic 
ganglia, yet develop basal forebrain cholinergic neurons that survive for the life span of the 
mice. Animals homozygous for NGF disruption failed to respond to noxious mechanical 
stimuli. Histological analysis revealed profound cell loss in both sensory and sympathetic 
ganglia but examination of the central nervous system revealed that basal forebrain 
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cholinergic neurons differentiated and continued to express phenotypic markers for the life 
span of the null mutant mice. These observations confirm the critical dependence of 
peripheral sensory and sympathetic neurons on NGF but demonstrated that differentiation 
and initial survival of central NGF-responsive neurons can occur in the absence of NGF [46]. 
 
p75 neurotrophin receptor gene knockout mice 
Mice with a target mutation of the p75 neurotrophin receptor gene exhibit a substantial loss 
of neurons within sensory ganglia and a deficit of nociceptive function [47]. Mice 
homozygous for the mutation were viable and fertile. The mutation did not decrease the size 
of sympathetic ganglia or the density of sympathetic innervation of the iris or salivary gland. 
Subsequent studies, however, have revealed that there are substantial sympathetic 
abnormalities in these mice [48]. Pineal glands lacked innervation and sweat gland 
innervation was absent or reduced in particular footpads. The phenotype of homozygous mice 
is somewhat reminiscent of a partial NGF deprivation [47-49]. 
 
TRKA (trkA) knockout mice 
Mice carrying a deletion in the tyrosine-kinase domain of the trkA gene have been generated 
by homologous recombination in embryonic stem cell [10, 27]. Mice lacking trkA have 
severe sensory and sympathetic neuropathies and most die within one month of birth. 
Animals homozygous for this mutation appear anatomically normal at birth and feed 
normally. However, by postnatal day 10 (P10), the trkA (-/-) mice are significantly smaller in 
size as compared to their (+/+) and (+/-) siblings and display a wide array of sensory defects. 
For instance, these mice do not react to noxious olfactory stimuli, such as ammonium 
hydroxide, and fail to react to deep pinpricks in either their whisker pads or their rear paws, 
indicating defects in their trigeminal and peripheral sensory neurons, respectively. In 
addition, these animals exhibit deficiencies in thermoception. 
By P20, surviving animals have miotic pupils and slight ptosis; when their eyes are 
illuminated, the iris constricts without efficient redilation, indicating that the parasympathetic 
component of the oculomotor nerve is intact but the sympathetic innervation from the 
superior cervical ganglion (SCG) is defective. In contrast, they respond normally to sound 
(handclap) and can discriminate 1% acetic acid from water, indicating that facial (VII), 
acoustic (VIII) and glossopharyngeal (IX) nerves function correctly. Basic motor functions 
also appear to be normal. But anhidrosis (inability to sweat) is not apparent [10]  
After 3 to 4 weeks, mutant mice develop a distinct pathology. Their fur becomes mottled 
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and numerous scabs appear over the entire body; their paws are covered by ulcerations and 
digits are missing, probably due to self-mutilation; their eyes exhibit corneal opacities, 
indicating there may be a sensory defect affecting the blink response. 
Neuroanatomical examination of the peripheral nervous system of these trkA (-/-) mice 
reveals extensive (>70%) neuronal cell loss in trigeminal, dorsal root, and sympathetic 
ganglia. In the dorsal root ganglia, the vast majority of the missing neurons correspond to 
those of small size, a population believed to be NGF dependent. At birth, the SCG of trkA 
(-/-) mice displays a significant loss of neurons, as well as large numbers of pyknotic nuclei, 
suggesting an active process of cell degeneration. At P10, the SCG is severely shrunken, and 
only a few principal sympathetic neurons can be found [10]. Disruption of the trkA gene does 
not appear to cause the loss of cholinergic neurons in the caudatoputamen and in the basal 
forebrain complex, two brain structures that have been previously shown to be targets for 
NGF [7,10]. However, adult trkA (-/-) mice exhibit a severe decrease in the cholinergic fibers 
that project from the medial septum to the hippocampus and from the nucleus basalis to the 
cerebral cortex. Whether TRKA receptors are required for the outgrowth of these cholinergic 
fibers or for maintenance of their cholinergic phenotype remains to be determined. 
 
Comparison of CIPA with trkA Knockout Mice 
Phenotypic features of CIPA and trkA knockout mice are compared in Table 1. 
Anatomical changes in the DRG neurons and spinal cord in trkA knockout mice are 
similar to those noted in CIPA [10]. These include absence of small neurons in the DRG, lack 
of small fibers in the dorsal roots, absence of Lissauer’s tract and reduction of the spinal tract 
of the trigeminal nerve [4]. Miotic pupils and slight ptosis associated with loss of neurons in 
the SCG are the features in these mice, suggesting a defect in sympathetic innervation. These 
findings are also reported in some patients with CIPA [15]. The autonomic ganglia and brain 
appeared normal in a patient with CIPA [4]. Why CIPA patients with the same apparent gene 
disruption do not show a deficiency in sympathetic ganglia may be due to species differences 
or, alternatively, sympathetic innervation in humans might be maintained or compensated for 
by a combination of other neurotrophin and receptor systems.   
 
TRKA is the responsible gene for CIPA 
 
Based on the intriguing data in animal models, we tested the hypothesis that NGF signaling 
might be involved in patients with CIPA. At first, we studied the p75 neurotrophin receptor 
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gene in a patient with CIPA because only its knockout mice were reported at that time [47]. 
Then, we examined the NGF gene itself, but we could not detect a putative mutation in either 
gene. Next, we analyzed the TRKA gene in three unrelated CIPA patients who had 
consanguineous parents. Three mutations in the TRKA – a deletion, a splicing and a missense 
mutation - were detected in these three families [11], which identified the genetic basis of 
CIPA as mutations in the TRKA gene. We then developed a comprehensive strategy to screen 
for the TRKA gene mutations [16, 50] and we characterized intragenic polymorphic sites and 
described the haplotypic association of mutant alleles [51]. We also studied effects of TRKA 
missense mutations on autophosphorylation of the RTK for NGF.  
 Human TRKA maps to chromosome 1q21-q22 [52] and is divided into 17 exons and 16 
introns [42,50, 53]. The entire sequence was estimated to span at least 23 kb, coding for a 
protein of 790 or 796 amino acid residues (Fig. 3). Six amino acid residues encoded by exon 
9 are in the extracellular domain of the neuronal-specific TRKA receptor [54]. The two 
isoforms differ from each other in the presence of 6 amino acid residues (VSFSPV) located in 
the extracellular domain near the transmembrane region. These additional sequences do not 
affect NGF binding. Moreover, these isoforms appear to have similar biological properties. 
However, the 796 amino acid long TRKA molecule is primarily expressed in neuronal cells, 
whereas the 790 amino acid long isoform has been found in cells of nonneuronal origin [54]. 
 
Mutations and polymorphisms   
 
We identified the genetic basis for CIPA when we detected loss-of-function mutations in the 
TRKA gene derived from affected patients [11]. Recently, we developed a strategy to screen 
for TRKA mutations, on the basis of the structure and organization of the gene [16, 50] and 
we characterized intragenic polymorphic sites [51].  
We have analyzed 32 CIPA families and detected a total of 25 mutations, including six 
frameshift, four nonsense, 11 missense and four splice mutations (Fig. 3). Three of these 
missense mutations are probably polymorphisms, as described later. There is a common 
founder mutation in the Japanese. In addition to these mutations, we have recently reported 
eight novel mutations [55]. Other investigators have also detected and reported TRKA 
mutations in CIPA patients [56-59]. Subsequently, a total of 37 different mutations including 
nine frameshift, seven nonsense, seven splice, and 14 missense mutations have been detected 
in CIPA families from various countries [60]. The mutations are located both in the 
extracellular and intracellular domains. Most are private mutations, but relatively common 
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mutations have been reported for particular ethnic groups such as Japanese and 
Israeli-Bedouins [51, 58]. At least eight missense mutations have been confirmed to cause 
defects in NGF-stimulated autophosphorylation of the TRKA protein by in vitro expression 
studies [61, 62]. The effect of other missense mutations remains to be determined.  
A number of polymorphisms have been reported [60]. Six non-synonymous amino acid 
substitutions have been described. Three, R85S, H598Y and G607V, were detected as double 
and triple mutations [16]. But these three are probably polymorphisms in a particular ethnic 
background according to an in vitro expression study [62] and various mutation and 
polymorphism searches [56, 58, 60]. The effect of other non-synonymous amino acid 
substitutions (G18E, G608V and R774Q) remains to be determined.  
 
Application of intragenic polymorphic sites for detection of unexpected mutations  
 
The IVS7-33T>A mutation is located upstream of the consensus splice acceptor site and was 
detected in five chromosomes from five Japanese patients [51]. Initial screening for TRKA 
mutations failed to identify this mutation. Analyses of intragenic polymorphic sites indicated 
that this mutation is linked to a very rare haplotype. Re-examination of DNA from patients 
revealed that the intronic mutation is involved in a putative branch-site critical for intron 
excision. Subsequently, the exon trap analysis showed that this causes an aberrant splicing in 
vitro. Thus, analysis of intragenic polymorphic sites can aid in identifying an unexpected 
mutation that can often escape detection.  
 
Functional studies of TRKA mutants 
 
Loss of TRKA function is self-evident in the frameshift, splice-site or nonsense mutations. In 
contrast, putative missense mutations require an expression study for confirmation as a cause 
of CIPA. Such studies provide an opportunity to consider the structure-function relationship 
of the TRKA protein as well as findings in other receptor tyrosine kinase families. We 
reported 11 putative missense mutations in CIPA families from various ethnic groups. We 
have introduced the corresponding mutations into the TRKA cDNA and examined 
NGF-stimulated autophosphorylation (Fig. 4). Two mutants (L93P and L213P) in the 
extracellular domain were aberrantly processed and showed diminished autophosphorylation 
[62]. Five mutants (G516R, G571R, R643W, R648C and G708S) in the tyrosine kinase 
domain were processed as wild-type TRKA but showed significantly diminished 
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autophosphorylation [62]. The G571R mutant was also studied by another group [61]. 
Another mutant (R774P) in the tyrosine kinase domain also showed significantly diminished 
autophosphorylation [57]. To date, eight of 14 putative missense mutations were confirmed to 
show diminished NGF-stimulated autophosphorylation [60]. Mutated residues (except for 
residue Arg-774) in the tyrosine kinase domain are conserved in various RTKs and probably 
contribute to critical functions of these proteins. Thus, naturally occurring TRKA missense 
mutations with loss of function provide considerable insight into the structure-function 
relationship in the RTK family. 
 
Genotype/phenotype relationship 
 
The genotype/phenotype correlation in the patients was not observed in a study of limited 
number of subjects [16, 51, 55]. The accumulated data favor the notion that there seems to be 
no genetic heterogeneity in CIPA. However, one cannot completely rule out the possibility 
that mutation(s) in other gene(s) are responsible for clinical phenotypes similar to CIPA [58]. 
TRKA mutations are detected in CIPA patients from various countries and most of them 
are private mutations [60]. But a relatively common mutation (R548fs) was noted in the 
Japanese [51]. Mutation analysis of TRKA indicated that more than 50% of 46 Japanese CIPA 
chromosomes share the same frameshift mutation. Haplotype analysis of the TRKA gene, 
based on intragenic polymorphic sites, showed that this mutation shows linkage 
disequilibrium with a rare haplotype in normal chromosomes. These findings strongly 
suggest that this mutation is a common founder mutation in the Japanese population. Another 
relatively common mutation (P615fs) was found in 16 of 19 unrelated CIPA families from 
Israeli-Bedouin people [58]. 
  
 
Conclusion and perspective 
 
The molecular pathology of CIPA provides unique opportunities to explore the critical role of 
the NGF-TRKA system in development and function of autonomic sympathetic nervous 
systems as well as sensory nervous systems that transmit noxious stimuli. Both NGF and 
TRKA (trkA) knockout mice resulted in dramatic phenotypes, but because the mice do not 
survive beyond one month of life behavioral studies are not feasible, whereas patients with 
CIPA often survive into adulthood if they receive careful treatment. Thus, CIPA can serve as 
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a useful human model to determine mechanisms of development and maintenance of 
NGF-dependent neurons in autonomic, sensory and central nervous systems, as well as the 
physiology of these neurons. Behavioral studies of CIPA patients may reveal critical roles of 
sympathetic and afferent neurons in the human physiology.  
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FIGURES 
 
Fig. 1  Neurotransmitter mediators of the axon reflex. 
 
 
 
Fig. 1  Neurotransmitter mediators of the axon reflex.   
Chemical mediators can sensitize and activate nociceptive neurons (or polymodal receptors) 
and stimulate the axon reflex. Activation of these receptors and neurons leads to the release 
of substance P and CGRP. Histamine, a chemical mediator and pilocarpine, a cholinergic 
agent probably can cause the axon reflex flare and axon reflex sweating as shown on left and 
right sides, respectively. Substance P produces plasma extravasation and CGRP produces 
dilatation of peripheral blood vessels. 
 (SP substance P, CGRP calcitonin gene related peptide, Ach acetylcholine). 
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Fig. 2  The binding of nerve growth factor (NGF) to the NGF/TRKA receptor. 
 
 
 
Fig. 2  The binding of nerve growth factor (NGF) to the NGF/TRKA receptor. 
The binding of the tightly associated NGF dimer to TRKA protein stimulates homodimer 
formation [43]. TRKA is phosphorylated in response to NGF, which is essential for 
intracellular signal transduction. The domain structure of TRKA protein with 790 or 796 
amino acids are shown [44]: SP signal peptide; CC-1 and CC-2 the first and second cysteine 
clusters, respectively; LRMs leucine-rich motifs; Ig-1 and Ig-2 the first and second 
immunoglobulin-like motifs, respectively; TM transmembrane; JX juxtamembrane; TK 
tyrosine kinase. A single transmembrane domain divides the TRKA protein into an 
extracellular and an intracellular domain. The extracellular domain is important for specific 
NGF binding. The intracellular domain includes a tyrosine kinase domain. Phosphorylated 
tyrosine residues –490, 670, 674, 675 and 785 in the TRKA cytoplasmic domain serve as 
anchor for binding downstream signaling molecules [45].  
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Fig. 3  Location of human TRKA mutations associated with congenital insensitivity to 
pain with anhidrosis (CIPA). 
 
 
 
Fig. 3  Location of human TRKA mutations associated with congenital insensitivity to pain 
with anhidrosis (CIPA).    
The human TRKA gene, located on chromosome 1 (1q21-q22), is divided into 17 exons and 
16 introns [50]. The entire sequence was estimated to span at least 23 kb, coding for a protein 
of 790 or 796 amino acid residues. Abbreviations on the bottom row indicate the domain 
structures encoded by the corresponding exon(s) [44, 50]. Multiple mutations have been 
described.  
An asterisk denotes the common Japanese founder mutation (G548fs). In addition to these 
mutations, we have recently reported eight novel mutations [55]. Three mutations in brackets 
are probably polymorphisms in a particular ethnic background, as described in text. 
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Fig. 4  Expression study of mutant TRKA cDNAs and autophosphorylation of their 
products.  
 
 
 
Fig. 4  Expression study of mutant TRKA cDNAs and autophosphorylaton of their products.  
A. Expression of the wild-type TRKA cDNA and processing and autophosphorylation of 
its product in a neuronal cell line: SH-SY5Y.  
The full-length cDNA for human TRKA receptor was subcloned into a mammalian 
expression vector (pCAGGS). The TRKA expression plasmid was transfected into cells. Each 
cell transfected with the plasmid pCAGGS vector, without the TRKA insert, was used as a 
mock-treated control. Cells were incubated in the presence (+) or absence (-) of nerve growth 
factor (NGF) and were harvested for detection of the total or phosphorylated TRKA proteins 
by immunoblotting. An antibody recognizes the C-terminal TRKA protein (TRKA: upper 
panel). Two phospho-specific antibodies recognize the phosphorylated Tyr-490 residue 
(pY-490: middle panel) and Tyr-674/675 residues (pY-674/675: lower panel) of TRKA 
protein. The TRKA precursor protein was detected and processed to a 140 kDa- and a 110 
kDa-forms by glycosylation. An 80 kDa-form (arrow) is probably the unglycosylated 
 28
 
 
  
polypeptidic backbone of these proteins. The 140 kDa-form was strongly phosphorylated in 
response to NGF.  
B. TRKA cDNAs harboring putative eight missense mutations.  
TRKA cDNAs were prepared, using in vitro site-directed mutagenesis [62]. Each specific 
mutagenesis oligonucleotide was complementary to the wild-type TRKA cDNA, except for a 
region of mismatch. The mutant and the wild-type TRKA cDNAs were transfected into 
SH-SY5Y cells. Autophosphorylation of the TRKA protein was detected after stimulation 
with NGF. In the neuronal cell, wild-type TRKA precursor protein was processed into the 110 
kDa and mature 140 kDa forms and the latter only phosphorylated in an NGF-dependent 
manner. Two mutants (L93P and L213P) in the extracellular domain were aberrantly 
processed and showed diminished autophosphorylation (Lanes 1, 2). Five mutants (G516R, 
G571R, R643W, R648C and G708S) in the tyrosine kinase domain were processed as 
wild-type TRKA but showed significantly diminished autophosphorylation (Lanes 3, 4, 5, 6, 
8). One putative mutant D668Y might be a rare polymorphism or might impair the function 
of TRKA without compromising autophosphorylation (Lane 7). In contrast, the other three 
(R85S, H598Y and G607V) we detected as double or triple mutations are probably 
polymorphisms in a particular ethnic background (data not shown). These data are 
reproduced from our previous report [62]. 
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Table 1  Phenotypes of congenital insensitivity to pain with anhidrosis (CIPA) and
TRKA(trkA) knockout mice 
Phenotype CIPA mice 
   
Perinatal:   
 - Abnormal birth - - 
 - Failure to thrive - + 
 - Early death  - * 
 
+ 
(die within a month) 
   
Sensory system:   
 - Abnormal pain/temperature sensation + + 
 - Injury or ulcer of digits + + 
 - Self-mutilation + + 
 - Abnormal touch/position sensation  - - 
 - Abnormal peripheral small nerve fibers + + 
 - Abnormal dorsal root ganglia + + 
   
Sympathetic system:   
 - Abnormal sweating + ？ 
 - Abnormal piloerection  + ？ 
 - Miosis/ptosos + + 
 - Abnormal innervation of sweat glands + ？ 
 - Abnormal sympathetic ganglia ？ + 
   
Central nervous system:   
 - Mental retardation + ？ 
- Abnormal basal forebrain ？ + 
   
Symbols, + and - indicate the presence and absence of finding, respectively.  
 ? indicates non-confirmed finding 
＊Early death can occur in CIPA due to hyperpyrexia. 
 
